Harmony Biosciences CFO files Form 3 ownership

Harmony Biosciences Holdings, Inc. reported that its Chief Financial Officer, Glenn Reicin, filed an initial Form 3 insider ownership report.

Rhea-AI Filing Summary

Harmony Biosciences Holdings, Inc. reported that its Chief Financial Officer, Glenn Reicin, filed an initial Form 3 insider ownership report. The filing lists no stock transactions or derivative positions and shows zero shares bought, sold, or otherwise transacted at this time.

Key Figures

Buy transactions: 0 shares Sell transactions: 0 shares Net buy/sell shares: 0 shares

3 metrics

Buy transactions 0 shares Form 3 transactionSummary buyShares

Sell transactions 0 shares Form 3 transactionSummary sellShares

Net buy/sell shares 0 shares Form 3 transactionSummary netBuySellShares (neutral)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Harmony Biosciences (HRMY) Form 3 filing by CFO Glenn Reicin show?

The Form 3 shows CFO Glenn Reicin’s initial insider ownership status. It reports no stock or derivative transactions and zero shares bought, sold, or exercised, serving as a baseline disclosure of his position with Harmony Biosciences Holdings, Inc.

Did Harmony Biosciences CFO Glenn Reicin buy or sell HRMY shares in this Form 3?

No, the Form 3 reports no purchases or sales of HRMY shares by CFO Glenn Reicin. All transaction-related counts, including buys, sells, exercises, gifts, and tax withholdings, are listed as zero in this initial ownership statement.

Are there any stock options or derivatives reported for HRMY CFO Glenn Reicin?

No derivative positions are reported for CFO Glenn Reicin in this Form 3. The derivative summary is empty, and exercise-related fields such as exerciseCount and exerciseShares are disclosed as zero, indicating no options or similar instruments in this filing.

Does the Harmony Biosciences Form 3 for HRMY indicate any gifts or restructuring transactions?

The Form 3 indicates no gifts or restructuring-related transactions. GiftCount, giftShares, restructuringCount, and restructuringShares are all reported as zero, so there are no transfers by gift or entity restructuring events associated with Glenn Reicin in this disclosure.

What is the net buy or sell position reported for HRMY CFO Glenn Reicin?

The filing reports a neutral net position for CFO Glenn Reicin. NetBuySellShares is zero and netBuySellDirection is listed as neutral, reflecting that no share purchases or sales occurred in connection with this Form 3 submission.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 04:12 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Reicin Glenn

(Last) (First) (Middle)

C/O HARMONY BIOSCIENCES HOLDINGS, INC.

(Street)

PLYMOUTH MEETING PENNSYLVANIA 19462

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/14/2026

3. Issuer Name and Ticker or Trading Symbol
Harmony Biosciences Holdings, Inc. [ HRMY ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF FINANCIAL OFFICER

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Christian Ulrich, Attorney-in-Fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)